| scholarly article | Q13442814 |
| P50 | author | Laurent P Lacroix | Q44615698 |
| P2093 | author name string | A Ong | |
| L A Dawson | |||
| C Jennings | |||
| E Southam | |||
| M H Harries | |||
| K A Waters | |||
| M L Woolley | |||
| D N C Jones | |||
| D J Pemberton | |||
| J E Gartlon | |||
| F Shaughnessy | |||
| P2860 | cites work | Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates | Q21092790 |
| A synaptic model of memory: long-term potentiation in the hippocampus | Q22337276 | ||
| Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam | Q24529847 | ||
| Facilitation of glutamate receptors enhances memory | Q24561847 | ||
| 5‐HT6 receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex | Q28184669 | ||
| Chronic elevation of brain-derived neurotrophic factor by ampakines | Q28191459 | ||
| Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data | Q30981408 | ||
| BDNF and activity-dependent synaptic modulation | Q33820669 | ||
| A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia | Q33845380 | ||
| Effects of S 18986-1, a novel cognitive enhancer, on memory performances in an object recognition task in rats | Q33912264 | ||
| Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures | Q33970238 | ||
| AMPA receptor potentiators for the treatment of CNS disorders | Q33978906 | ||
| The neurotrophin hypothesis for synaptic plasticity. | Q34117599 | ||
| LY404187: a novel positive allosteric modulator of AMPA receptors | Q34152191 | ||
| Role of AMPA receptor endocytosis in synaptic plasticity | Q34238072 | ||
| The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. | Q34280771 | ||
| Synaptic plasticity and AMPA receptor trafficking | Q34284847 | ||
| S 18986, a positive modulator of AMPA receptors with cognition-enhancing properties, increases ACh release in the hippocampus of young and aged rat. | Q34319847 | ||
| Synaptic mechanisms of associative memory in the amygdala. | Q34450234 | ||
| A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia | Q34579324 | ||
| Ionotropic and metabotropic glutamate receptor structure and pharmacology | Q36054635 | ||
| A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data | Q36441017 | ||
| Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia | Q37929204 | ||
| Some effects of piracetam (UCB 6215 nootropyl) on chronic schizophrenia | Q39696319 | ||
| Neurotrophins and brain insults. | Q40397648 | ||
| Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons. | Q41713135 | ||
| Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats | Q42197982 | ||
| Effects of nootropic drugs in a scopolamine-induced amnesia model in mice | Q42209088 | ||
| Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine | Q42219659 | ||
| S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures | Q42509030 | ||
| Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. | Q43641859 | ||
| Differential autoreceptor control of extracellular 5-HT in guinea pig and rat: species and regional differences | Q44780795 | ||
| AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices | Q44867384 | ||
| Ampakines and the threefold path to cognitive enhancement | Q46042539 | ||
| Impaired recognition memory in rats after damage to the hippocampus. | Q46121652 | ||
| A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task | Q46449228 | ||
| 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats | Q46450693 | ||
| Synaptic expression of glutamate receptor after encoding of fear memory in the rat amygdala | Q46748254 | ||
| A pathway-specific function for different AMPA receptor subunits in amygdala long-term potentiation and fear conditioning | Q46956785 | ||
| Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. | Q47353682 | ||
| Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices | Q48200320 | ||
| Fear and the brain: where have we been, and where are we going? | Q48324583 | ||
| Impaired object recognition memory in rats following ischemia-induced damage to the hippocampus | Q48336723 | ||
| Effects of lesions of the Substantia Innominata/Ventral Pallidum, globus pallidus and medial septum on rat's performance in object-recognition and radial-maze tasks: physostigmine and amphetamine treatments. | Q48375698 | ||
| Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons | Q48403898 | ||
| Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity. | Q48493242 | ||
| An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study | Q48493249 | ||
| Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix | Q48778698 | ||
| Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator | Q48844088 | ||
| Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family | Q48888641 | ||
| Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat. | Q48903641 | ||
| A new one-trial test for neurobiological studies of memory in rats. II: Effects of piracetam and pramiracetam | Q48922237 | ||
| AMPA receptor facilitation accelerates fear learning without altering the level of conditioned fear acquired. | Q51101728 | ||
| LTP is accompanied by commensurate enhancement of auditory-evoked responses in a fear conditioning circuit. | Q51123376 | ||
| Enhancement by an ampakine of memory encoding in humans. | Q51999656 | ||
| Lesions of rat perirhinal cortex exacerbate the memory deficit observed following damage to the fimbria-fornix. | Q52014632 | ||
| Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat. | Q52044825 | ||
| Modulation of learning processes by ionotropic glutamate receptor ligands. | Q52052008 | ||
| 1-BCP, a memory-enhancing agent, selectively potentiates AMPA-induced [3H]norepinephrine release in rat hippocampal slices. | Q52054427 | ||
| Medial frontal cortex mediates perceptual attentional set shifting in the rat. | Q52168274 | ||
| Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons. | Q52206556 | ||
| A simple objective technique for measuring flexibility in thinking. | Q55050827 | ||
| P433 | issue | 1-3 | |
| P304 | page(s) | 343-354 | |
| P577 | publication date | 2008-09-16 | |
| P1433 | published in | Psychopharmacology | Q1422802 |
| P1476 | title | Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat. | |
| P478 | volume | 202 |
| Q38421802 | AMPA receptor-positive allosteric modulators for the treatment of schizophrenia: an overview of recent patent applications |
| Q92490605 | Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders |
| Q33870362 | Challenges for and current status of research into positive modulators of AMPA receptors. |
| Q34121778 | Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate |
| Q34829339 | Glutamatergic targets for enhancing extinction learning in drug addiction |
| Q39069024 | Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator |
| Q34661221 | Pharmacological enhancement of memory and executive functioning in laboratory animals. |
| Q47406216 | Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia. |
| Q26864400 | Profile of minocycline and its potential in the treatment of schizophrenia |
| Q37753296 | Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders. |
| Q41050258 | S 47445 Produces Antidepressant- and Anxiolytic-Like Effects through Neurogenesis Dependent and Independent Mechanisms. |
| Q42254092 | The role of 5-HT2C receptors in touchscreen visual reversal learning in the rat: a cross-site study |
| Q34190402 | Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576. |
| Q37465460 | nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms. |
Search more.